{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:09:18Z","timestamp":1789762158340,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Weight gain is commonly regarded as a hallmark of hypothyroidism,although supporting evidence is limited. Consequently, restoration of euthyroidism with levothyroxine is often expected to induce clinically meaningful weight loss or return to premorbid body weight. These expectations may affect patient counseling, treatment satisfaction, and interpretation of persistent symptoms after biochemical correction. This systematic review and metanalysis aimed to synthesize available evidence on changes in body weight(BW) and anthropometric parameters, including body mass index(BMI), waist circumference(WC), fat mass(FM), and lean body mass(LBM), after levothyroxine treatment in hypothyroid adults achieving euthyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of PubMed and Google Scholar was conducted up to April 1, 2026, to identify original English-language studies reporting anthropometric outcomes before levothyroxine initiation and after achievement of euthyroidism. For each outcome, effect size was calculated as mean change from baseline to post-treatment. When appropriate, heterogeneity was explored through subgroup analyses or meta-regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-three studies including 763 patients were analyzed.Levothyroxine treatment was associated with significant reductions in BW (\u22121.39\u2009kg; 95% CI: \u22122.56 to \u22120.23),BMI (\u22120.39\u2009kg\/m\u00b2; 95% CI: \u22120.68 to \u22120.11), FM (\u22120.75\u2009kg; 95% CI: \u22121.47 to \u22120.02), and LBM (\u22120.95\u2009kg; 95% CI: \u22121.47 to \u22120.43). Subgroup analyses showed significant reductions in BW and BMI in overt hypothyroidism, but not in subclinical hypothyroidism. Conversely, LBM decreased significantly only in subclinical hypothyroidism. Baseline TSH and study duration were not associated with changes in anthropometric outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Achieving euthyroidism with levothyroxine produces modest reductions in BW, BMI, FM, and LBM. Effects appear partly influenced by disease severity, with more consistent BW and BMI reductions in overt hypothyroidism. These findings support realistic counseling and discourage levothyroxine use solely for weight loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-026-02224-x","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:30:26Z","timestamp":1789759826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levothyroxine therapy for euthyroidism restoration results in clinically insignificant weight and anthropometric changes: a systematic review and meta-analysis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-2388","authenticated-orcid":false,"given":"Sium","family":"Wolde Sellasie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ossola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Trimboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2224_CR1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"A Garmendia Madariaga","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99:923\u201331. https:\/\/doi.org\/10.1210\/jc.2013-2409.","journal-title":"J Clin Endocrinol Metab"},{"key":"2224_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14:301\u201316. https:\/\/doi.org\/10.1038\/nrendo.2018.18.","journal-title":"Nat Rev Endocrinol"},{"key":"2224_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-022-00357-7","volume":"8","author":"L Chaker","year":"2022","unstructured":"Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8:30. https:\/\/doi.org\/10.1038\/s41572-022-00357-7.","journal-title":"Nat Rev Dis Primers"},{"key":"2224_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S2213-8587(18)30371-1","volume":"7","author":"J Jonklaas","year":"2019","unstructured":"Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 2019;7:473\u201383. https:\/\/doi.org\/10.1016\/S2213-8587(18)30371-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2224_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-25-0123","volume":"14","author":"M Centanni","year":"2025","unstructured":"Centanni M, Duntas L, Feldt-Rasmussen U, Koehrle J, Peeters RP, Razvi S, et al. ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism. Eur Thyroid J. 2025;14:e250123. https:\/\/doi.org\/10.1530\/ETJ-25-0123.","journal-title":"Eur Thyroid J"},{"key":"2224_CR6","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-14-0067","volume":"171","author":"F Santini","year":"2014","unstructured":"Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014;171:R137\u2013R152. https:\/\/doi.org\/10.1530\/EJE-14-0067.","journal-title":"Eur J Endocrinol"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/nu16010087","volume":"16","author":"B Biondi","year":"2023","unstructured":"Biondi B. Subclinical hypothyroidism in patients with obesity and metabolic syndrome: a narrative review. Nutrients. 2023;16:87. https:\/\/doi.org\/10.3390\/nu16010087.","journal-title":"Nutrients"},{"key":"2224_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"SH Pearce","year":"2013","unstructured":"Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215\u201328. https:\/\/doi.org\/10.1159\/000356507.","journal-title":"Eur Thyroid J"},{"key":"2224_CR9","doi-asserted-by":"publisher","first-page":"l2006","DOI":"10.1136\/bmj.l2006","volume":"365","author":"GE Bekkering","year":"2019","unstructured":"Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019;365:l2006. https:\/\/doi.org\/10.1136\/bmj.l2006.","journal-title":"BMJ"},{"key":"2224_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27:1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"key":"2224_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"2224_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00455.x.","journal-title":"Biometrics"},{"key":"2224_CR15","doi-asserted-by":"publisher","first-page":"e230314","DOI":"10.1530\/EC-23-0314","volume":"12","author":"BR Medici","year":"2023","unstructured":"Medici BR, Nygaard B, la Cour JL, Krakauer M, Br\u00f8nden A, Sonne MP, et al. Effects of levothyroxine substitution therapy on hunger and food intake in individuals with hypothyroidism. Endocr Connect. 2023;12:e230314 https:\/\/doi.org\/10.1530\/EC-23-0314.","journal-title":"Endocr Connect"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/a-1968-0106","volume":"55","author":"L Hanke","year":"2023","unstructured":"Hanke L, Poeten P, Spanke L, Britz S, Diel P. The influence of levothyroxine on body composition and physical performance in subclinical hypothyroidism. Horm Metab Res. 2023;55:51\u20138. https:\/\/doi.org\/10.1055\/a-1968-0106.","journal-title":"Horm Metab Res"},{"key":"2224_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5577217","volume":"2021","author":"BB Medici","year":"2021","unstructured":"Medici BB, Lerche la Cour J, Knop FK, Krakauer M, Michaelsson LF, Faber J, et al. Predictors of improvement in quality of life when treating hypothyroidism. J Thyroid Res. 2021;2021:5577217. https:\/\/doi.org\/10.1155\/2021\/5577217.","journal-title":"J Thyroid Res"},{"key":"2224_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2174\/1871530319666191105123005","volume":"20","author":"R Pasandideh","year":"2020","unstructured":"Pasandideh R, Hosseini SM, Veghari G, Hezarkhani S. The effects of 8 weeks of levothyroxine replacement treatment on metabolic and anthropometric indices of insulin resistance in hypothyroid patients. Endocr Metab Immune Disord Drug Targets. 2020;20:745\u201352. https:\/\/doi.org\/10.2174\/1871530319666191105123005.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/IJGM.S206983","volume":"12","author":"M R\u00edos-Prego","year":"2019","unstructured":"R\u00edos-Prego M, Anibarro L, S\u00e1nchez-Sobrino P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. Int J Gen Med. 2019;12:299\u2013304. https:\/\/doi.org\/10.2147\/IJGM.S206983.","journal-title":"Int J Gen Med"},{"key":"2224_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/thy.2018.0436","volume":"29","author":"CI Maushart","year":"2019","unstructured":"Maushart CI, Loeliger R, Gashi G, Christ-Crain M, Betz MJ. Resolution of hypothyroidism restores cold-induced thermogenesis in humans. Thyroid. 2019;29:493\u2013501. https:\/\/doi.org\/10.1089\/thy.2018.0436.","journal-title":"Thyroid"},{"key":"2224_CR21","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.5603\/KP.a2016.0053","volume":"74","author":"I Sayin","year":"2016","unstructured":"Sayin I, Erkan AF, Ekici B, Kutuk U, Corakci A, Tore HF. Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism. Kardiol Pol. 2016;74:1492\u20138. https:\/\/doi.org\/10.5603\/KP.a2016.0053.","journal-title":"Kardiol Pol"},{"key":"2224_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000448889","volume":"5","author":"S Sirigiri","year":"2016","unstructured":"Sirigiri S, Vaikkakara S, Sachan A, Srinivasarao PVLN, Epuri S, Anantarapu S, et al. Correction of hypothyroidism leads to change in lean body mass without altering insulin resistance. Eur Thyroid J. 2016;5:247\u201352. https:\/\/doi.org\/10.1159\/000448889.","journal-title":"Eur Thyroid J"},{"key":"2224_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5603\/EP.a2016.0025","volume":"67","author":"A Stangierski","year":"2016","unstructured":"Stangierski A, Rucha\u0142a M, Krauze T, Moczko J, Guzik P. Treatment of severe thyroid function disorders and changes in body composition. Endokrynol Pol. 2016;67:359\u201366. https:\/\/doi.org\/10.5603\/EP.a2016.0025.","journal-title":"Endokrynol Pol"},{"key":"2224_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12020-014-0460-2","volume":"49","author":"ET Cerit","year":"2015","unstructured":"Cerit ET, Akturk M, Altinova AE, Tavil Y, Ozkan C, Yayla C, et al. Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism. Endocrine. 2015;49:196\u2013203. https:\/\/doi.org\/10.1007\/s12020-014-0460-2.","journal-title":"Endocrine"},{"key":"2224_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4158\/EP14072.OR","volume":"20","author":"SY Lee","year":"2014","unstructured":"Lee SY, Braverman LE, Pearce EN. Changes in body weight after treatment of primary hypothyroidism with levothyroxine. Endocr Pract. 2014;20:1122\u20138. https:\/\/doi.org\/10.4158\/EP14072.OR.","journal-title":"Endocr Pract"},{"key":"2224_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/ijcp.12394","volume":"68","author":"P Anagnostis","year":"2014","unstructured":"Anagnostis P, Efstathiadou ZA, Slavakis A, Selalmatzidou D, Poulasouchidou M, Katergari S, et al. The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism. Int J Clin Pract. 2014;68:857\u201363. https:\/\/doi.org\/10.1111\/ijcp.12394.","journal-title":"Int J Clin Pract"},{"key":"2224_CR27","doi-asserted-by":"publisher","first-page":"E2341","DOI":"10.1210\/jc.2014-2112","volume":"99","author":"T Scherer","year":"2014","unstructured":"Scherer T, Wolf P, Winhofer Y, Duan H, Einwallner E, Gessl A, et al. Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. J Clin Endocrinol Metab. 2014;99:E2341\u2013E2346. https:\/\/doi.org\/10.1210\/jc.2014-2112.","journal-title":"J Clin Endocrinol Metab"},{"key":"2224_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/576794","volume":"2013","author":"O Bakiner","year":"2013","unstructured":"Bakiner O, Bozkirli E, Ersozlu Bozkirli ED, Ozsahin K. Correction of hypothyroidism seems to have no effect on body fat. Int J Endocrinol. 2013;2013:576794. https:\/\/doi.org\/10.1155\/2013\/576794.","journal-title":"Int J Endocrinol"},{"key":"2224_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.12659\/MSM.883847","volume":"19","author":"DY Aksoy","year":"2013","unstructured":"Aksoy DY, Cinar N, Harmanci A, Karakaya J, Yildiz BO, Usman A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Med Sci Monit. 2013;19:210\u20135. https:\/\/doi.org\/10.12659\/MSM.883847.","journal-title":"Med Sci Monit"},{"key":"2224_CR30","first-page":"348","volume":"10","author":"F Kutluturk","year":"2013","unstructured":"Kutluturk F, Yuce S, Tasliyurt T, Yelken BM, Aytan P, Ozturk B, et al. Changes in metabolic and cardiovascular risk factors before and after treatment in overt hypothyroidism. Med Glas. 2013;10:348\u201353.","journal-title":"Med Glas"},{"key":"2224_CR31","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1210\/jc.2010-1521","volume":"96","author":"J Karmisholt","year":"2011","unstructured":"Karmisholt J, Andersen S, Laurberg P. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J Clin Endocrinol Metab. 2011;96:E99\u2013E103. https:\/\/doi.org\/10.1210\/jc.2010-1521.","journal-title":"J Clin Endocrinol Metab"},{"key":"2224_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF03346482","volume":"32","author":"M Ozkaya","year":"2009","unstructured":"Ozkaya M, Sahin M, Cakal E, Yuzbasioglu F, Sezer K, Kilinc M, et al. Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. J Endocrinol Investig. 2009;32:435\u20139. https:\/\/doi.org\/10.1007\/BF03346482.","journal-title":"J Endocrinol Investig"},{"key":"2224_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/thy.2007.0393","volume":"19","author":"PF Teixeira","year":"2009","unstructured":"Teixeira PF, Cabral MD, Silva NA, Soares DV, Braulio VB, Couto APCB, et al. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition. Thyroid. 2009;19:443\u201350. https:\/\/doi.org\/10.1089\/thy.2007.0393.","journal-title":"Thyroid"},{"key":"2224_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2796.2006.01652.x","volume":"260","author":"A Iqbal","year":"2006","unstructured":"Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Troms\u00f8 Study. J Intern Med. 2006;260:53\u201361. https:\/\/doi.org\/10.1111\/j.1365-2796.2006.01652.x.","journal-title":"J Intern Med"},{"key":"2224_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/BF03344159","volume":"29","author":"GE Krassas","year":"2006","unstructured":"Krassas GE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Kaltsas T. Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. J Endocrinol Investig. 2006;29:606\u201312. https:\/\/doi.org\/10.1007\/BF03344159.","journal-title":"J Endocrinol Investig"},{"key":"2224_CR36","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1210\/jc.2004-2344","volume":"90","author":"N Caraccio","year":"2005","unstructured":"Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A, et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab. 2005;90:4057\u201362. https:\/\/doi.org\/10.1210\/jc.2004-2344.","journal-title":"J Clin Endocrinol Metab"},{"key":"2224_CR37","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/ndt\/16.9.1799","volume":"16","author":"CW Park","year":"2001","unstructured":"Park CW, Shin YS, Ahn SJ, Kim SY, Choi EJ, Chang YS, et al. Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema. Nephrol Dial Transplant. 2001;16:1799\u2013806. https:\/\/doi.org\/10.1093\/ndt\/16.9.1799.","journal-title":"Nephrol Dial Transplant"},{"key":"2224_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1079\/bjn19910073","volume":"65","author":"P Deurenberg","year":"1991","unstructured":"Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65:105\u201314. https:\/\/doi.org\/10.1079\/bjn19910073.","journal-title":"Br J Nutr"},{"key":"2224_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol. 2024;20:261\u201377. https:\/\/doi.org\/10.1038\/s41574-023-00943-z.","journal-title":"Nat Rev Endocrinol"},{"key":"2224_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40618-024-02409-z","volume":"48","author":"JC Galofr\u00e9","year":"2025","unstructured":"Galofr\u00e9 JC, D\u00edez JJ, Attanasio R, Nagy EV, Negro R, Papini E, et al. Treatment of obesity with thyroid hormones in Europe. Data from the THESIS* Collaboration. J Endocrinol Investig. 2025;48:201\u201312. https:\/\/doi.org\/10.1007\/s40618-024-02409-z.","journal-title":"J Endocrinol Investig"},{"key":"2224_CR41","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1001\/jama.290.22.2952","volume":"290","author":"PW Clyde","year":"2003","unstructured":"Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290:2952\u20138. https:\/\/doi.org\/10.1001\/jama.290.22.2952.","journal-title":"JAMA"},{"key":"2224_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11154-025-09988-z","volume":"26","author":"D Kretli-Souza","year":"2025","unstructured":"Kretli-Souza D, Paulino NE, Asevedo RA, Lemos SCL, Meireles-Oliveira G, Alves-Silva Y, et al. Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis. Rev Endocr Metab Disord. 2025;26:1037\u201350. https:\/\/doi.org\/10.1007\/s11154-025-09988-z.","journal-title":"Rev Endocr Metab Disord"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02224-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:30:27Z","timestamp":1789759827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":42,"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02224-x","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PT has been a consultant for Institut Biochimique SA (Switzerland).","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}